Novel technologies to detect minimal residual disease (MRD)
Todd E. Druley
News from the lymphoma special interest group at BSH
How are drug development and clinical trials changing?
Pharmacoeconomics of mobilization
What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?